Skip to Main Content
Try STAT+ TODAY
Trending:
Health
STAT+
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

What Trump pushback? Bayer takes hefty price hikes on two cancer drugs in just six months

  • Ed Silverman

By Ed Silverman June 7, 2018

Reprints
Markus Schreiber/AP

Even as the Trump administration looks for ways to mollify angry consumers over rising drug prices, some companies continue to push the proverbial envelope.

Take Bayer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Chinese DNA giant’s U.S. affiliate looks to rival Illumina,…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
Mindstrong’s demise and the future of mental health care
Mindstrong’s demise and the future of mental health care
Experts debate: Are we playing with fire when we…
Experts debate: Are we playing with fire when we edit human genes?
Pharma loses a court battle in its bid to…
Pharma loses a court battle in its bid to block states from importing drugs from Canada
Pharmalittle: Biden to call for expanding caps on insulin…
Pharmalittle: Biden to call for expanding caps on insulin prices; families seek to override Vertex CF…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina,…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers

Recommended Stories